EUVIMEDEUVIMED entdecken
Crossref

Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex

Zhongyu Wang, Li Wei, Junfeng Lin, Can Huang, Huitong Chen, Dong Fan, Weiyu Hu, Jing Liu, Huaiyi Huang iD, Zongming Wang, Xin Wang

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Zhongyu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R China. Hauptthemen laut MEDLINE: Photochemotherapy, Antineoplastic Agents, Ruthenium, Photosensitizing Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Bureau, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy has been regarded as a noninvasive treatment for cancer with spatiotemporal control over drug activation. Bis-terpyridyl Ru(II) complexes exhibit a promising achiral structure but suffer from low photoreactivity due to deviation from the ideal octahedral geometry. Herein, we introduce the donor-acceptor-donor motif to construct a dinuclear bis-terpyridyl Ru(II) complex (Ru2). Ru2 exhibits superior light absorption properties compared with mononuclear complex Ru1. Importantly, upon 595 nm light excitation, Ru2 shows promising synergetic type I/II photosensitization and photocatalytic activity, while Ru1 is inactive. Anticancer mechanistic studies reflect that Ru2 induces intracellular redox imbalance and affects the biosynthetic and metabolic processes, leading to cell apoptosis. Overall, this work provides a simple strategy to rouse the PDT efficiency of bis-terpyridyl Ru(II) complexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyAntineoplastic AgentsRutheniumPhotosensitizing AgentsCoordination ComplexesHumansApoptosisCell Line, TumorPyridinesDrug Screening Assays, AntitumorMolecular StructureStructure-Activity Relationship

Substanzen

Antineoplastic AgentsRutheniumPhotosensitizing AgentsCoordination ComplexesPyridines

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R China.
  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong 518107, P.R China.
  • Department of Pharmacy, Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong 518107, P.R China.
  • Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R China.

ORCID-Profile: Huaiyi Huang

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangzhou Municipal Science and Technology Bureau
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Traditional Chinese Medicine Bureau of Guangdong Province

Zitieren

APA

Wang, Z., Wei, L., Lin, J., Huang, C., Chen, H., Fan, D., Hu, W., Liu, J., Huang, H., Wang, Z., & Wang, X. (2024). Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01307

Vancouver

Wang Z, Wei L, Lin J, Huang C, Chen H, Fan D, et al. Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01307

BibTeX
@article{Wang2024,
  author = {Wang, Zhongyu and Wei, Li and Lin, Junfeng and Huang, Can and Chen, Huitong and Fan, Dong and Hu, Weiyu and Liu, Jing and Huang, Huaiyi and Wang, Zongming and Wang, Xin},
  title = {Donor–Acceptor–Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01307}
}
Kostenlos starten →